Monoclonal Antibodies In Veterinary Health Market Report 2026
Monoclonal Antibodies In Veterinary Health Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Monoclonal Antibodies In Veterinary Health Market Report 2026

Global Outlook – By Product (Monoclonal Antibodies (mAbs), Glucocorticoids, Antihistamines, Immunosuppressants, Other Products), By Animal Type (Dogs, Cats, Horses, Livestock, Other Animals), By Indication (Allergic Skin Disease, Autoimmune Disorders, Infectious Diseases, Cancer Or Tumor Therapy, Other Indications), By Route Of Administration (Injectable, Oral, Topical), By Distribution Channel (Veterinary Clinics, Specialized Animal Hospitals, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Monoclonal Antibodies In Veterinary Health Market Overview

• Monoclonal Antibodies In Veterinary Health market size has reached to $0.92 billion in 2025

• Expected to grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%

• Growth Driver: Rising Animal Disease Incidences Drive Growth Of Monoclonal Antibodies In Veterinary Health Market

• Market Trend: New Monoclonal Antibody Treatments For Osteoarthritis In Pets

North America was the largest region in 2025.

What Is Covered Under Monoclonal Antibodies In Veterinary Health Market?

Monoclonal antibodies in veterinary health are specialized proteins engineered to target and neutralize specific pathogens or toxins in animals, aiding in the diagnosis and treatment of various diseases. They are created by cloning a single type of immune cell to produce identical antibodies that precisely bind to their target.

The main types of animals in monoclonal antibodies in veterinary health are dogs and others. A dog refers to a domesticated mammal (Canis lupus familiaris) that is commonly kept as a pet or working animal. These antibodies find applications in dermatology, pain management, and others, serving end users such as veterinary hospitals and others.

Monoclonal Antibodies In Veterinary Health market report bar graph

What Is The Monoclonal Antibodies In Veterinary Health Market Size and Share 2026?

The monoclonal antibodies in veterinary health market size has grown rapidly in recent years. It will grow from $0.92 billion in 2025 to $1.06 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to rising prevalence of canine cancers, increasing incidence of autoimmune disorders in pets, limited availability of targeted therapies, growth of veterinary hospitals, awareness of advanced veterinary treatments.

What Is The Monoclonal Antibodies In Veterinary Health Market Growth Forecast?

The monoclonal antibodies in veterinary health market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to technological advancements in mAb engineering, increasing adoption of species-specific therapies, rising investment in veterinary oncology and dermatology, growth of personalized veterinary medicine, expansion of global veterinary healthcare infrastructure. Major trends in the forecast period include growth in monoclonal antibody-based canine cancer treatments, rising use of mabs for autoimmune disorders in dogs, expansion of veterinary dermatology applications, increasing adoption of targeted pain management therapies, development of species-specific antibody therapies for cats, horses, and livestock.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Monoclonal Antibodies In Veterinary Health Market Segmentation

1) By Product: Monoclonal Antibodies (mAbs), Glucocorticoids, Antihistamines, Immunosuppressants, Other Products

2) By Animal Type: Dogs, Cats, Horses, Livestock, Other Animals

3) By Indication: Allergic Skin Disease, Autoimmune Disorders, Infectious Diseases, Cancer Or Tumor Therapy, Other Indications

4) By Route Of Administration: Injectable, Oral, Topical

5) By Distribution Channel: Veterinary Clinics, Specialized Animal Hospitals, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:

1) By Monoclonal Antibodies: Lokivetmab, Felvetmab, Investigational Monoclonal Antibodies, Equine-specific mAbs

2) By Glucocorticoids: Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Hydrocortisone, Triamcinolone

3) By Antihistamines: Diphenhydramine, Hydroxyzine, Cetirizine, Loratadine, Chlorpheniramine

4) By Immunosuppressants: Cyclosporine, Tacrolimus, Azathioprine, Mycophenolate Mofetil

5) By Other Products: Essential Fatty Acid Supplements, Medicated Shampoos And Sprays, Allergen-Specific Immunotherapy (ASIT), Skin Barrier Repair Creams, Nutraceuticals And Probiotics

What Is The Driver Of The Monoclonal Antibodies In Veterinary Health Market?

The rising animal disease incidences are expected to propel the growth of the monoclonal antibodies in veterinary health market going forward. The rising incidence of animal diseases is driven by intensified farming practices, which increase the risk of infectious disease spread, and climate change, which expands the range of disease vectors such as ticks and mosquitoes. Monoclonal antibodies are highly useful for treating animal diseases as they target specific pathogens or proteins involved in disease processes, offering precise and effective treatments. For instance, in June 2024, according to a report published by the GOV.UK, a UK-based government website, between April 2023 and March 2024, the number of animals slaughtered due to TB incidents rose by 5% in England to 21,298, and by 17% in Wales to 11,197. The rising animal disease incidences are driving the growth of monoclonal antibodies in veterinary health industry.

Key Players In The Global Monoclonal Antibodies In Veterinary Health Market

Major companies operating in the monoclonal antibodies in veterinary health market are Zoetis Inc, Boehringer Ingelheim International GmbH, MSD Animal Health, Elanco Animal Health Incorporated, Heska Corporation, Ceva Santé Animale S.A., Biogénesis Bagó S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol, Phibro Animal Health, Norbrook Laboratories, AnimalCare, Eco Animal Health, Venkys, Hester Biosciences Limited, ImmuCell

Global Monoclonal Antibodies In Veterinary Health Market Trends and Insights

Major companies operating in the monoclonal antibodies in veterinary health market are focusing on developing innovative veterinary therapeutic solutions, such as anti-NGF monoclonal antibody treatment to address conditions such as chronic pain and inflammation in animals. Anti-NGF monoclonal antibody treatment refers to a therapeutic approach that targets and inhibits nerve growth factor (NGF) to reduce pain and inflammation in animals suffering from chronic pain conditions. For instance, in May 2023, Zoetis, a US-based animal health company, received FDA approvals for Librela (bedinvetmab injection), the first monoclonal antibody treatment for controlling pain associated with osteoarthritis (OA) in dogs, which is administered as a once-monthly injection, and Apoquel Chewable, the first chewable medication specifically for managing allergic itch and inflammation in dogs aged one year or older. Librela is a monoclonal antibody that targets and inhibits nerve growth factor (NGF). By blocking NGF, Librela helps to prevent these pain signals from reaching the brain, thereby reducing the sensation of pain in dogs with osteoarthritis. Librela represents a significant advancement in veterinary pain management, providing a novel approach to treating chronic pain in dogs.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Monoclonal Antibodies In Veterinary Health Market?

In January 2024, Ceva Santé Animale, a France-based provider of animal health products and services, acquired Scout Bio Inc. for an undisclosed amount. With this acquisition, Ceva Santé aims to significantly enhance its global biotechnology efforts in animal health by leveraging Scout Bio's expertise in advanced therapies such as gene therapy and monoclonal antibodies, accelerating innovation to address chronic diseases in pets. Scout Bio Inc. is a US-based biotechnology company revolutionizing and developing a pipeline of monoclonal antibody therapies for chronic conditions in pets.

Regional Outlook

North America was the largest region in the monoclonal antibodies in veterinary health market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Monoclonal Antibodies In Veterinary Health Market?

The monoclonal antibodies in veterinary health market consist of sales of diagnostic kits, therapeutic drugs, research reagents, monoclonal antibody drugs, and therapeutic formulations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Monoclonal Antibodies In Veterinary Health Market Report 2026?

The monoclonal antibodies in veterinary health market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the monoclonal antibodies in veterinary health industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Monoclonal Antibodies In Veterinary Health Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.06 billion
Revenue Forecast In 2035 $1.85 billion
Growth Rate CAGR of 15.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Animal Type, Indication, Route Of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Zoetis Inc, Boehringer Ingelheim International GmbH, MSD Animal Health, Elanco Animal Health Incorporated, Heska Corporation, Ceva Santé Animale S.A., Biogénesis Bagó S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol, Phibro Animal Health, Norbrook Laboratories, AnimalCare, Eco Animal Health, Venkys, Hester Biosciences Limited, ImmuCell
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Monoclonal Antibodies In Veterinary Health Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Monoclonal Antibodies In Veterinary Health Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Monoclonal Antibodies In Veterinary Health Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Monoclonal Antibodies In Veterinary Health Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Industry 4.0 & Intelligent Manufacturing

4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.3 Biotechnology, Genomics & Precision Medicine

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Digitalization, Cloud, Big Data & Cybersecurity

4.2. Major Trends

4.2.1 Growth In Monoclonal Antibody-Based Canine Cancer Treatments

4.2.2 Rising Use Of Mabs For Autoimmune Disorders In Dogs

4.2.3 Expansion Of Veterinary Dermatology Applications

4.2.4 Increasing Adoption Of Targeted Pain Management Therapies

4.2.5 Development Of Species-Specific Antibody Therapies For Cats, Horses, And Livestock

5. Monoclonal Antibodies In Veterinary Health Market Analysis Of End Use Industries

5.1 Veterinary Hospitals

5.2 Pet Clinics

5.3 Research Institutions

5.4 Animal Care Centers

5.5 Specialty Veterinary Centers

6. Monoclonal Antibodies In Veterinary Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Monoclonal Antibodies In Veterinary Health Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Monoclonal Antibodies In Veterinary Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Monoclonal Antibodies In Veterinary Health Market Size, Comparisons And Growth Rate Analysis

7.3. Global Monoclonal Antibodies In Veterinary Health Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Monoclonal Antibodies In Veterinary Health Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Monoclonal Antibodies In Veterinary Health Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Monoclonal Antibodies In Veterinary Health Market Segmentation

9.1. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies (mAbs), Glucocorticoids, Antihistamines, Immunosuppressants, Other Products

9.2. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dogs, Cats, Horses, Livestock, Other Animals

9.3. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Allergic Skin Disease, Autoimmune Disorders, Infectious Diseases, Cancer Or Tumor Therapy, Other Indications

9.4. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable, Oral, Topical

9.5. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Veterinary Clinics, Specialized Animal Hospitals, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.6. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lokivetmab, Felvetmab, Investigational Monoclonal Antibodies, Equine-specific mAbs

9.7. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Hydrocortisone, Triamcinolone

9.8. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diphenhydramine, Hydroxyzine, Cetirizine, Loratadine, Chlorpheniramine

9.9. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cyclosporine, Tacrolimus, Azathioprine, Mycophenolate Mofetil

9.10. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Essential Fatty Acid Supplements, Medicated Shampoos And Sprays, Allergen-Specific Immunotherapy (ASIT), Skin Barrier Repair Creams, Nutraceuticals And Probiotics

10. Monoclonal Antibodies In Veterinary Health Market Regional And Country Analysis

10.1. Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market

11.1. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Monoclonal Antibodies In Veterinary Health Market

12.1. China Monoclonal Antibodies In Veterinary Health Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Monoclonal Antibodies In Veterinary Health Market

13.1. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Monoclonal Antibodies In Veterinary Health Market

14.1. Japan Monoclonal Antibodies In Veterinary Health Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Monoclonal Antibodies In Veterinary Health Market

15.1. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Monoclonal Antibodies In Veterinary Health Market

16.1. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Monoclonal Antibodies In Veterinary Health Market

17.1. South Korea Monoclonal Antibodies In Veterinary Health Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Monoclonal Antibodies In Veterinary Health Market

18.1. Taiwan Monoclonal Antibodies In Veterinary Health Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Monoclonal Antibodies In Veterinary Health Market

19.1. South East Asia Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Monoclonal Antibodies In Veterinary Health Market

20.1. Western Europe Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Monoclonal Antibodies In Veterinary Health Market

21.1. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Monoclonal Antibodies In Veterinary Health Market

22.1. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Monoclonal Antibodies In Veterinary Health Market

23.1. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Monoclonal Antibodies In Veterinary Health Market

24.1. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Monoclonal Antibodies In Veterinary Health Market

25.1. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Monoclonal Antibodies In Veterinary Health Market

26.1. Eastern Europe Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Monoclonal Antibodies In Veterinary Health Market

27.1. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Monoclonal Antibodies In Veterinary Health Market

28.1. North America Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Monoclonal Antibodies In Veterinary Health Market

29.1. USA Monoclonal Antibodies In Veterinary Health Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Monoclonal Antibodies In Veterinary Health Market

30.1. Canada Monoclonal Antibodies In Veterinary Health Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Monoclonal Antibodies In Veterinary Health Market

31.1. South America Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Monoclonal Antibodies In Veterinary Health Market

32.1. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Monoclonal Antibodies In Veterinary Health Market

33.1. Middle East Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Monoclonal Antibodies In Veterinary Health Market

34.1. Africa Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Monoclonal Antibodies In Veterinary Health Market Regulatory and Investment Landscape

36. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Company Profiles

36.1. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Monoclonal Antibodies In Veterinary Health Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Monoclonal Antibodies In Veterinary Health Market Company Profiles

36.3.1. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

36.3.3. MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Heska Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Monoclonal Antibodies In Veterinary Health Market Other Major And Innovative Companies

Ceva Santé Animale S.A., Biogénesis Bagó S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol

38. Global Monoclonal Antibodies In Veterinary Health Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Monoclonal Antibodies In Veterinary Health Market

40. Monoclonal Antibodies In Veterinary Health Market High Potential Countries, Segments and Strategies

40.1 Monoclonal Antibodies In Veterinary Health Market In 2030 - Countries Offering Most New Opportunities

40.2 Monoclonal Antibodies In Veterinary Health Market In 2030 - Segments Offering Most New Opportunities

40.3 Monoclonal Antibodies In Veterinary Health Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Monoclonal Antibodies In Veterinary Health Market, Overview Of Key Products - Product Examples
  • Table 2: Global Monoclonal Antibodies In Veterinary Health Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Monoclonal Antibodies In Veterinary Health Market, Supply Chain Analysis
  • Table 4: Global Monoclonal Antibodies In Veterinary Health Market, Major Raw Material Providers
  • Table 5: Global Monoclonal Antibodies In Veterinary Health Market, Major Resource Providers
  • Table 6: Global Monoclonal Antibodies In Veterinary Health Market, Major Manufacturers (Suppliers)
  • Table 7: Global Monoclonal Antibodies In Veterinary Health Market, Major Distributors And Channel Partners
  • Table 8: Global Monoclonal Antibodies In Veterinary Health Market, Key Technologies & Future Trends
  • Table 9: Global Monoclonal Antibodies In Veterinary Health Market, Major Trends
  • Table 10: Global Monoclonal Antibodies In Veterinary Health Market, Major End Users
  • Table 11: Global Monoclonal Antibodies In Veterinary Health Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Monoclonal Antibodies In Veterinary Health Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Monoclonal Antibodies In Veterinary Health Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Monoclonal Antibodies In Veterinary Health Market - TAM, US$ Billion, 2025
  • Table 15: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Monoclonal Antibodies In Veterinary Health Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Monoclonal Antibodies In Veterinary Health Market - Company Scoring Matrix
  • Table 101: Zoetis Inc Financial Performance
  • Table 102: Boehringer Ingelheim International GmbH Financial Performance
  • Table 103: MSD Animal Health Financial Performance
  • Table 104: Elanco Animal Health Incorporated Financial Performance
  • Table 105: Heska Corporation Financial Performance
  • Table 106: Global Monoclonal Antibodies In Veterinary Health Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Monoclonal Antibodies In Veterinary Health Market, Competitive Dashboard
  • Table 108: Global Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 110: Global, Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), Segmentation By Animal Type, 2025 – 2030
  • Table 111: Global, Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Monoclonal Antibodies In Veterinary Health Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Monoclonal Antibodies In Veterinary Health Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Monoclonal Antibodies In Veterinary Health Market, Supply Chain Analysis
  • Figure 4: Global Monoclonal Antibodies In Veterinary Health Market, Major Raw Material Providers
  • Figure 5: Global Monoclonal Antibodies In Veterinary Health Market, Major Resource Providers
  • Figure 6: Global Monoclonal Antibodies In Veterinary Health Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Monoclonal Antibodies In Veterinary Health Market, Major Distributors And Channel Partners
  • Figure 8: Global Monoclonal Antibodies In Veterinary Health Market, Key Technologies & Future Trends
  • Figure 9: Global Monoclonal Antibodies In Veterinary Health Market, Major Trends
  • Figure 10: Global Monoclonal Antibodies In Veterinary Health Market, Major End Users
  • Figure 11: Global Monoclonal Antibodies In Veterinary Health Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Monoclonal Antibodies In Veterinary Health Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Monoclonal Antibodies In Veterinary Health Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Monoclonal Antibodies In Veterinary Health Market - TAM, US$ Billion, 2025
  • Figure 15: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Monoclonal Antibodies In Veterinary Health Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Monoclonal Antibodies In Veterinary Health Market - Company Scoring Matrix
  • Figure 101: Zoetis Inc Financial Performance
  • Figure 102: Boehringer Ingelheim International GmbH Financial Performance
  • Figure 103: MSD Animal Health Financial Performance
  • Figure 104: Elanco Animal Health Incorporated Financial Performance
  • Figure 105: Heska Corporation Financial Performance
  • Figure 106: Global Monoclonal Antibodies In Veterinary Health Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Monoclonal Antibodies In Veterinary Health Market, Competitive Dashboard
  • Figure 108: Global Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 110: Global, Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), Segmentation By Animal Type, 2025 – 2030
  • Figure 111: Global, Monoclonal Antibodies In Veterinary Health Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Frequently Asked Questions

The Monoclonal Antibodies In Veterinary Health market was valued at $0.92 billion in 2025, increased to $1.06 billion in 2026, and is projected to reach $1.85 billion by 2030.

The global Monoclonal Antibodies In Veterinary Health market is expected to grow at a CAGR of 14.8% from 2026 to 2035 to reach $1.85 billion by 2035.

Some Key Players in the Monoclonal Antibodies In Veterinary Health market Include, Zoetis Inc, Boehringer Ingelheim International GmbH, MSD Animal Health, Elanco Animal Health Incorporated, Heska Corporation, Ceva Santé Animale S.A., Biogénesis Bagó S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol, Phibro Animal Health, Norbrook Laboratories, AnimalCare, Eco Animal Health, Venkys, Hester Biosciences Limited, ImmuCell .

Major trend in this market includes: New Monoclonal Antibody Treatments For Osteoarthritis In Pets. For further insights on this market. request a sample here

North America was the largest region in the monoclonal antibodies in veterinary health market in 2025. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts